Eagle Global Advisors Has Decreased Magellan Midstream Prtnrs LP (MMP) Stake; Falcon Point Capital Has Upped By $2.51 Million Its Amag Pharmaceuticals (AMAG) Position

February 18, 2018 - By Winifred Garcia

Eagle Global Advisors Llc decreased Magellan Midstream Prtnrs Lp (MMP) stake by 1.02% reported in 2017Q3 SEC filing. Eagle Global Advisors Llc sold 21,090 shares as Magellan Midstream Prtnrs Lp (MMP)’s stock declined 7.68%. The Eagle Global Advisors Llc holds 2.05 million shares with $145.91 million value, down from 2.07 million last quarter. Magellan Midstream Prtnrs Lp now has $15.20 billion valuation. The stock decreased 0.92% or $0.62 during the last trading session, reaching $66.64. About 1.12 million shares traded or 21.52% up from the average. Magellan Midstream Partners, L.P. (NYSE:MMP) has risen 3.55% since February 18, 2017 and is uptrending. It has underperformed by 13.15% the S&P500.

Falcon Point Capital Llc increased Amag Pharmaceuticals Inc. (AMAG) stake by 24.87% reported in 2017Q3 SEC filing. Falcon Point Capital Llc acquired 167,175 shares as Amag Pharmaceuticals Inc. (AMAG)’s stock declined 21.74%. The Falcon Point Capital Llc holds 839,477 shares with $13.18 million value, up from 672,302 last quarter. Amag Pharmaceuticals Inc. now has $654.43 million valuation. The stock increased 3.06% or $0.55 during the last trading session, reaching $18.5. About 2.88M shares traded or 171.90% up from the average. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has risen 3.00% since February 18, 2017 and is uptrending. It has underperformed by 13.70% the S&P500.

Investors sentiment increased to 1.44 in Q3 2017. Its up 0.35, from 1.09 in 2017Q2. It improved, as 21 investors sold AMAG shares while 43 reduced holdings. 35 funds opened positions while 57 raised stakes. 39.98 million shares or 4.47% less from 41.85 million shares in 2017Q2 were reported. Zebra Cap Limited Liability Company accumulated 0.08% or 13,332 shares. Stevens Capital Mngmt Lp owns 26,084 shares. Rhumbline Advisers has invested 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Dupont Management holds 0.01% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) for 19,731 shares. Citigroup holds 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) or 80,028 shares. Brandywine Global Invest Mngmt Ltd Liability Com has 0.01% invested in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Tocqueville Asset Management Ltd Partnership invested in 0.05% or 214,510 shares. Highland Mngmt LP owns 61,500 shares or 0.05% of their US portfolio. Pub Employees Retirement Association Of Colorado stated it has 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Price T Rowe Associates Inc Md holds 0% or 196,586 shares. Federated Invsts Pa has invested 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). The Ontario – Canada-based Canada Pension Plan Board has invested 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Moreover, Globeflex Capital Lp has 0.08% invested in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) for 15,377 shares. Meeder Asset Mgmt stated it has 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Renaissance Tech Ltd Co has invested 0.01% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG).

Since August 29, 2017, it had 0 insider buys, and 1 insider sale for $20,938 activity. On Tuesday, August 29 the insider Vittiglio Joseph sold $20,938.

Among 14 analysts covering AMAG Pharmaceuticals (NASDAQ:AMAG), 4 have Buy rating, 1 Sell and 9 Hold. Therefore 29% are positive. AMAG Pharmaceuticals had 41 analyst reports since August 18, 2015 according to SRatingsIntel. As per Monday, June 26, the company rating was maintained by Cantor Fitzgerald. The rating was maintained by Deutsche Bank on Wednesday, November 4 with “Hold”. Janney Capital upgraded the stock to “Buy” rating in Thursday, February 15 report. The stock of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has “Hold” rating given on Thursday, November 19 by Deutsche Bank. The stock of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has “Hold” rating given on Thursday, November 2 by Cantor Fitzgerald. Morgan Stanley initiated the stock with “Buy” rating in Friday, September 8 report. The stock of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) earned “Buy” rating by Jefferies on Thursday, February 15. The company was maintained on Wednesday, February 14 by Piper Jaffray. The firm has “Equal-Weight” rating by Barclays Capital given on Thursday, January 21. Leerink Swann maintained the shares of AMAG in report on Wednesday, May 4 with “Outperform” rating.

Falcon Point Capital Llc decreased Capital Senior Living Corp. (NYSE:CSU) stake by 39,815 shares to 777,240 valued at $10.34M in 2017Q3. It also reduced Calamp Corp. (NASDAQ:CAMP) stake by 49,490 shares and now owns 864,700 shares. Avadel Pharmaceuticals Plc (Ad was reduced too.

Eagle Global Advisors Llc increased Cheniere Energy Partners Lp (NYSEMKT:CQP) stake by 61,620 shares to 1.94M valued at $55.87M in 2017Q3. It also upped Banco Macro Sa (NYSE:BMA) stake by 3,000 shares and now owns 14,000 shares. Nustar Gp Holdings Llc (NYSE:NSH) was raised too.

Since September 14, 2017, it had 0 insider purchases, and 1 insider sale for $353,200 activity. On Thursday, September 14 Selvidge Jeff R sold $353,200 worth of Magellan Midstream Partners, L.P. (NYSE:MMP) or 5,000 shares.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>